Current Drug Targets : Impact Factor & More

eISSN: 1873-5592pISSN: 1389-4501

Check your submission readiness

Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.

Current Drug Targets Key Metrics

CiteScore
6.1
Impact Factor
< 5
SJR
Q2Pharmacology
SNIP
0.86

Topics Covered on Current Drug Targets

Polyethylene glycol
Colorectal cancer
Review article
Immune system
Oxidative stress
Crohn's disease
Drug delivery
Carcinogenesis
Sexual dysfunction
Hepatocellular carcinoma
Immune checkpoint
Fibroblast growth factor
Type 2 diabetes
Renal replacement therapy
Heart failure
Chronic stress
Artificial intelligence
Photosensitizer
Drug discovery
Ovarian cancer

Current Drug Targets Journal Specifications

Overview
Publisher BENTHAM SCIENCE PUBL LTD
Language English
Frequency Semi-monthly
General Details
LanguageEnglish
FrequencySemi-monthly
Publication Start Year2000
Publisher URLVisit website
Website URLVisit website
View less
NEW

Submissions Pack

Expert Services + AI tools

One subscription packed with expert publication services and AI tools to get you published

Brought to you by
  • Journal Selection Service

    Benefit from our experts' recommendations of 3-5 best-suited journals, accompanied by a detailed Journal Selection report explaining the choices. Make informed decisions.

  • Journal Submission Service

    Streamline your submission process with meticulous manuscript formatting to meet journal guidelines, crafting a tailored cover letter for the editor, and hassle-free account creation and submission

Bundle of AI tools for your research needs

Journal Finder, Paperpal, R Discovery, MindTheGraph and more

View benefits in detail

Buy now for a special Launch price!

$199
$249

Planning to publish in Current Drug Targets ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Compare Similar Journals with Current Drug Targets

Select Journals to Compare with Current Drug Targets
Total journals - 9
You can select up to 3 Journals at a time

International Journal of Molecular Sciences

Publisher: MDPI

Scientific Reports

Publisher: NATURE PORTFOLIO

Frontiers in Immunology

Publisher: FRONTIERS MEDIA SA

Frontiers in Pharmacology

Publisher: FRONTIERS MEDIA SA

PLoS ONE

Publisher: PUBLIC LIBRARY SCIENCE

Biomedicine and Pharmacotherapy

Publisher: ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER

Molecules

Publisher: MDPI

Cells

Publisher: MDPI

Cancers

Publisher: MDPI
0 Journals Selected to compare with
Current Drug Targets
Compare journals across 7 parameters SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers

SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers

Get detailed Journal comparison report on your email by signing up

Check if your research matches the topics covered in Current Drug Targets?

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Check your research

FAQs on Current Drug Targets

How long has Current Drug Targets been actively publishing? Faqs

Current Drug Targets has been in operation since 2000 till date.

What is the publishing frequency of Current Drug Targets? Faqs

Current Drug Targets published with a Semi-monthly frequency.

How many articles did Current Drug Targets publish last year? Faqs

In 2023, Current Drug Targets publsihed 21 articles.

What is the eISSN & pISSN for Current Drug Targets? Faqs

For Current Drug Targets, eISSN is 1873-5592 and pISSN is 1389-4501.

What is Citescore for Current Drug Targets? Faqs

Citescore for Current Drug Targets is 6.1.

What is SNIP score for Current Drug Targets? Faqs

SNIP score for Current Drug Targets is 0.86.

What is the SJR for Current Drug Targets? Faqs

SJR for Current Drug Targets is Q2.

Who is the publisher of Current Drug Targets? Faqs

BENTHAM SCIENCE PUBL LTD is the publisher of Current Drug Targets.